The title compound, C 30H 34FNO 7S, is a key intermediate in the design of dual 5-LOX (5-lipoxygenase)/COX-2 (cyclooxygenase-2) inhibitors. The compound crystallizes as a racemate. Linear hydrogen-bonded chains are aligned along the  direction, and stacked π-π interactions and C - H⋯O contacts stabilize the crystal structure.
|Journal||Acta crystallographica Section C: Crystal Structure communications|
|Publication status||Published - 1 Feb 2006|